Liven Pharma Cash Flow Statement

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	-701.22	-584.46	41.74	-12.33	-14.29	-14.63
Depreciation & Amortization	29.42	27.17	24.87	13.1	14.56	16.08
Other Amortization	328.27	328.27	0.69	-	-	-
Provision & Write-off of Bad Debts	126.44	116.87	-	-	-	-
Other Operating Activities	120.8	92.58	1.15	-2.9	-3.22	-3.55
Change in Accounts Receivable	106.38	-21.52	-42.29	-	-	-
Change in Inventory	122.74	0.46	-11.82	-	-	-
Change in Accounts Payable	17.89	39.43	0.21	-	-0.07	-4.16
Change in Other Net Operating Assets	-9.33	-0.52	-0.75	-0.14	0.76	-0.52
Operating Cash Flow	216.89	-1.72	13.8	-2.27	-2.26	-6.79
Capital Expenditures	-32.16	-22.84	-	-	-	-
Sale (Purchase) of Intangibles	-12.76	-10	-	-	-	-
Investing Cash Flow	-237.45	-32.84	-	-	-	-
Short-Term Debt Issued	-	168.72	11.34	2.27	2.24	6.79
Long-Term Debt Issued	-	6.68	1.36	-	-	-
Total Debt Issued	-0.02	175.4	12.7	2.27	2.24	6.79
Short-Term Debt Repaid	-	-156.14	-	-	-	-
Long-Term Debt Repaid	-	-1.8	-3.54	-	-	-
Total Debt Repaid	-8.31	-157.94	-3.54	-	-	-
Net Debt Issued (Repaid)	-8.34	17.46	9.16	2.27	2.24	6.79
Financing Cash Flow	191.66	17.46	9.16	2.27	2.24	6.79
Miscellaneous Cash Flow Adjustments	-17.32	0.03	-	-	-	-
Net Cash Flow	153.79	-17.07	22.96	0	-0.02	-0.01
Free Cash Flow	184.72	-24.56	13.8	-2.27	-2.26	-6.79
Free Cash Flow Margin	186.39%	-19.30%	5.63%	-	-	-
Free Cash Flow Per Share	2.05	-0.35	345.08	-0.19	-0.19	-0.56
Cash Interest Paid	0.47	0.47	0.1	-	-	-
Levered Free Cash Flow	152.36	151.56	-163.82	3.45	4.31	0.03
Unlevered Free Cash Flow	153.78	152.02	-163.81	3.45	4.31	0.03
Change in Working Capital	237.68	17.84	-54.65	-0.14	0.7	-4.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.